• Latest
  • Trending
  • All
  • Egypt
  • Business
  • Local
  • World
US health panel says Merck pill can prevent grave Covid infections

US health panel says Merck pill can prevent grave Covid infections

November 27, 2021
Trump weighing new Iran strikes as Israel presses for action

Trump weighing new Iran strikes as Israel presses for action

November 19, 2026
Sadat’s peace legacy ‘a responsibility’, Abdelatty tells Congress

Sadat’s peace legacy ‘a responsibility’, Abdelatty tells Congress

November 19, 2026
Egypt FM, US House speaker discuss Gaza, regional security

Egypt FM, US House speaker discuss Gaza, regional security

November 19, 2026
US House Speaker Mike Johnson

Sadat’s 1977 Knesset address still inspires, says US House Speaker

November 19, 2026
Egypt PM welcomes Libya’s Dbeibah on official visit

Egypt PM welcomes Libya’s Dbeibah on official visit

November 19, 2026
FM: Egypt’s stability, diplomacy key to regional security

FM: Egypt’s stability, diplomacy key to regional security

November 19, 2026
Russia, China, Iran say IAEA work can resume once fighting ends

Russia, China, Iran say IAEA work can resume once fighting ends

November 18, 2026
Sisi sees off Saudi Crown Prince at Cairo Airport

Sisi praises US Congress for honouring Sadat with Gold Medal

November 18, 2026
US Congress honours Sadat with highest civilian award

US Congress honours Sadat with highest civilian award

November 18, 2026

Gov’t expands hydraulic fracturing, horizontal drilling to boost oil, gas production

November 18, 2026
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, November 19, 2026
  • Login

Editor-in-Chief

Mohamed Fahmy

Board Chairman

Tarek Lotfy

Egyptian Gazette
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
No Result
View All Result
Egyptian Gazette
Home Entertainment Health

US health panel says Merck pill can prevent grave Covid infections

by News Wires
November 27, 2021
in Health
This October 18, 2021 handout photo courtesy of Merck & Co,Inc. shows capsules of the antiviral pill molnupiravir.

This October 18, 2021 handout photo courtesy of Merck & Co,Inc. shows capsules of the antiviral pill molnupiravir.

Share on FacebookWhatsapp

WASHINGTON – An anti-Covid pill developed by Merck has proved effective in treating the disease, the US Food and Drug Administration said in a much-awaited preliminary report.

 

But the report, from an FDA advisory panel, cautioned that pregnant women should not use the drug, known as molnupiravir, saying the potential benefits do not outweigh the risks for those patients.

 

The report is meant to provide guidance to an FDA experts panel convening Tuesday to consider whether to authorize emergency use of molnupiravir.

Approval, analysts say, would represent a major step forward in the battle against the global pandemic, handing healthcare professionals a powerful new tool to help those infected.

 

Merck released the full results of the drug’s clinical trial Friday, which found the pill would reduce by 30 per cent — much lower than its initial figure — the rate of hospitalizations and deaths in high-risk Covid patients who took it soon after infection.

 

The preliminary FDA report confirmed the drug’s effectiveness in patients with mild to moderate Covid or at risk of hospitalization, AFP reported.

In adding a caution against the drug’s use by pregnant women, the report noted that no pregnant women were included in the clinical trials.

 

But it said tests involving pregnant rats and rabbits found higher rates of developing underweight and malformed fetuses after taking the drug.

It cited “both known and possibly unknown risks … in pregnant or lactating individuals and pediatric patients.”

 

Merck, in its authorization request, said its data stemmed from trials conducted in partnership with Ridgeback Biotherapeutics in people with mild to moderate cases of Covid-19 and with at least one additional risk factor.

 

They were given the drug within five days of symptoms first appearing.

Merck initially said the drug, in a clinical trial, had been found to halve the rate of hospitalizations and deaths, before decreasing the rate in Friday’s full results.

 

Those interim results were produced on the basis of studying slightly more than 700 patients, half of whom received the pill and half of whom got a placebo.

The finding — a 48 percent reduction rate — was statistically significant, and considered persuasive enough that an independent data review committee decided, in consultation with the FDA, to halt the drug trial ahead of schedule.

 

The full results were based on analysis of more than 1,400 patients, resulting in the more modest reduction rate of hospitalization and death.

Both the interim and complete results “support the efficacy and overall favorable benefit-risk assessment of molnupiravir” for treating mild to moderate Covid-19 in high risk adults, Merck said in a press release.

 

The full results found the hospitalization rate among patients who received the drug was 6.8 percent, compared to 9.7 percent for those given a placebo.

Just one of those treated died, while the second group saw nine deaths.

 

Antiviral drugs like molnupiravir work by reducing the ability of a virus to reproduce itself.

The drugs may be useful not only in keeping infected people from developing more serious symptoms, but in preventing people who have had prolonged exposure to the virus from falling ill.

 

The pill can be dispensed by a pharmacy and taken at home, whereas the three authorized monoclonal antibodies authorized for treating mild to moderate Covid-19 in at-risk individuals must be administered intravenously or through injection, the FDA report noted.

Tags: Covid-19MerckUSA

Discussion about this post

ADVERTISEMENT
egyptian-gazette-logo

The Egyptian Gazette is the oldest English-language daily newspaper in the Middle East.
It was first published on January 26, 1880 and it is part of El Tahrir Printing and Publishing House.

Follow Us

Trump weighing new Iran strikes as Israel presses for action

Sadat’s peace legacy ‘a responsibility’, Abdelatty tells Congress

Egypt FM, US House speaker discuss Gaza, regional security

Sadat’s 1977 Knesset address still inspires, says US House Speaker

Egypt PM welcomes Libya’s Dbeibah on official visit

  • Advertise
  • Privacy & Policy
  • Contact

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
    • Tourism
    • Odd News
  • Skyward
    • Snippets from EgyptAir history
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.